Current Rheumatology Reports

, 10:321

Idiopathic inflammatory myopathy: Treatment options

Article

DOI: 10.1007/s11926-008-0051-4

Cite this article as:
DiMartino, S.J. Curr Rheumatol Rep (2008) 10: 321. doi:10.1007/s11926-008-0051-4
  • 56 Downloads

Abstract

Idiopathic inflammatory myopathy (IIM) comprises a group of rare disorders in which there is an immune-mediated attack on skeletal muscle, the consequence of which is muscle damage and weakness in the patient. As in other inflammatory diseases, the general approach to therapy is use of immunosuppressive agents. Many options exist for IIM treatment, but therapeutic approaches are based mostly on empirical evidence and small studies, many of which are uncontrolled. Recently, new agents have been designed to target specific components of the immune response, and they offer hope for more effective or safer IIM therapy.

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Weill Medical CollegeCornell UniversityNew YorkUSA
  2. 2.Hospital for Special SurgeryNew YorkUSA